Indian study shows Covid XBB.1.16 raising conjunctivitis risk in infants

New Delhi, April 22: Amid the recent rise in Covid-19 cases in India, driven by the subvariant of Omicron XBB.1.16, there has been an increase in risk of conjunctivitis among children aged below one-year, according to a study, not yet peer-reviewed.

Related Keywords

Bijnor ,Uttar Pradesh ,India ,New Delhi ,Delhi ,Vipinm Vashishtha ,Tina Datta ,Research Centre In Bijnor ,Young ,Twitter ,Safety Net ,Mangla Hospital ,Research Centre ,